Scott Carmer Named as CEO of Orgenesis North America
04 août 2014 09h00 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 4, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of...
Orgenesis Signs Agreement With MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes
07 juil. 2014 08h40 HE
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Jul 7, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine today announced that its Belgian...
Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research
25 juin 2014 08h31 HE
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Jun 25, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5...
Orgenesis Awarded Maryland Stem Cell Research Fund Grant
29 mai 2014 14h16 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - May 29, 2014) - Orgenesis Inc. (OTCQB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into...
Orgenesis Appoints Joseph Tenne as Chief Financial Officer
21 avr. 2014 08h31 HE
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Apr 21, 2014) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells...
Orgenesis Secures $3 Million in Funding From Kodiak Capital Group
18 déc. 2013 11h01 HE
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Dec 18, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...
Orgenesis CSO & Founder, Dr. Sarah Ferber, to Present at the 2013 World Stem Cell Summit on December 4
03 déc. 2013 17h03 HE
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Dec 3, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...
Orgenesis Establishes Belgium Subsidiary for Manufacturing Process Development of Clinical Grade Cells
05 nov. 2013 08h31 HE
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Nov 5, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...
Orgenesis to Present at the 2013 Gateway Conference on September 10
04 sept. 2013 17h15 HE
|
Orgenesis Inc.
SAN FRANCISCO, CA--(Marketwired - Sep 4, 2013) - Orgenesis, Inc. (OTCBB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells...
Orgenesis Inc. Increases Depth of Governance With Latest Board Appointee
08 mai 2012 09h00 HE
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwire - May 8, 2012) - Orgenesis Inc. (OTCBB: ORGS) ("Orgenesis" or the "Company"), a development stage company with a novel therapeutic technology dedicated to convert a...